Stock Upgrades Today See Wall Street Boost Confidence

 TopRated
 
  TopRated
 
Follow  Message
 
 
 
TopRatedStocks uncovering top-rated companies. Providing quick insights and recommendations, they help investors discover high-potential stocks based on robust metrics.
 

•  12 Nov 2025
 

•   ACHR  
   
  +3.22%
•   ACRE  
   
  -0.41%
•   AER  
   
  -0.12%
•   ALC  
   
  -1.04%
•   ALL  
   
  +0.40%

$ACHR Archer Aviation remains a focus for growth traders. Canaccord Genuity keeps a Buy with a 45.8% upside. Investors eyeing electric vertical takeoff aircraft and green mobility trends are paying attention.

$ACRE Ares Commercial Real Estate sees a neutral stance with Market Perform from Keefe Bruyette & Woods and a 9.11% downside. A cautious play in commercial real estate where stability trumps rapid growth.

$AER AerCap Holdings retains a Positive rating from Susquehanna, though near-term upside is minimal at 0.10% downside. Resilient performance in aircraft leasing attracts defensive investors.

$ALC Alcon impresses with Mizuho’s Outperform rating and 38.72% projected upside. A leader in ophthalmic products with both growth and defensive qualities for long-term investors.

$ALL Allstate benefits from an Outperform with 16.27% upside. Strong fundamentals in property and casualty insurance make it a reliable moderate growth and dividend play.

$AMAT Applied Materials maintains a Buy despite 3.51% downside. Semiconductor equipment exposure and potential earnings recovery make it attractive for both growth and dividend-focused traders.

$APEI American Public Education earns multiple positive endorsements, projecting 14.16% upside. Niche in online and alternative education programs continues to inspire analyst confidence.

$ARLO Arlo Technologies stands out with a 53.56% upside. Smart home and security tech growth keeps it on traders’ radars for aggressive expansion plays.

$AVY Avery Dennison upgraded to Buy with a $200 price target. Labeling and packaging solutions plus dividend potential appeal to steady growth investors.

$BKD Brookdale Senior Living upgraded to Overweight by Barclays but with 24.22% downside projected. Patience required in senior housing amid near-term volatility.

$BKH Black Hills benefits from Scotiabank Outperform with a $81 target. Data center infrastructure growth drives balanced upside and dividend yield.

$BTDR Bitdeer Technologies Group sees 119.11% upside with a Buy rating. High-risk, high-reward play in crypto mining infrastructure.

$BUR Burford Capital shines with a 167.71% upside. Litigation finance niche offers aggressive growth potential.

$CAMT Camtek keeps Outperform with 15.25% upside. Semiconductor inspection and metrology demand supports mid-term growth.

$CEVA CEVA holds a Buy with 24.55% upside. Semiconductor IP licensing positions it well for AI, mobile, and connectivity expansion.

$CRVO Cervomed projects 188.50% upside. Clinical-stage biotech in pain management offers high-risk, high-reward potential.

$CRWV CoreWeave has mixed ratings; underperform from DA Davidson, Buy from Jefferies. 61.17% upside potential in cloud computing and AI infrastructure.

$CWAN Clearwater Analytics retains Buy with 71.54% upside. SaaS investment management growth makes it attractive for recurring revenue-focused investors.

$DK Delek US Holdings keeps Outperform despite 16.89% downside. Oil & gas volatility tempers near-term sentiment.

$DSP Viant Technology draws bullish consensus with 80.29% upside. Strong digital advertising and data-driven marketing appeal.

$EL Estée Lauder upgraded to Buy with 6.35% upside. Luxury consumer products provide lower-risk, steady growth.

$EMN Eastman Chemical sees a $75 price target and maintains Buy. Industrial & chemical tailwinds expected in 2026.

$EXPO Exponent retains Buy with $90 price target. AI adoption supports steady growth in professional consulting services.

$GSM Ferroglobe has 119.35% upside. Silicon and alloys exposure makes it an aggressive industrial growth pick.

$HOUS Anywhere Real Estate remains Market Perform with 37.41% downside. Residential real estate tech remains cautious.

$HUBB Hubbell maintains Buy with $515 target. Infrastructure and industrial investments provide solid growth potential.

$HWC Hancock Whitney keeps Market Perform with 22.22% upside. Measured opportunity for dividend-seeking investors.

$INOD Innodata maintains Buy with 27.36% upside. Steady demand in digital content and data processing drives growth.

$LECO Lincoln Electric sees $285 price target with Buy. Solid fundamentals in welding and automation support industrial growth.

$MET MetLife retains Outperform with 24.36% upside. Attractive combination of growth and dividends in insurance.

$MLM Martin Marietta Materials maintains Buy with 8.94% upside. Construction aggregates offer steady returns.

$MOS Mosaic upgraded to Buy. Fertilizer and agriculture fundamentals drive near-term gains.

$NCLH Norwegian Cruise Line holds Buy with 65.27% upside. Cruise recovery and strong bookings make it high-reward for tourism investors.

$OCS Oculis Holding continues Buy with 113.86% upside. Ophthalmic therapies and biotech optimism support growth.

$OM Outset Medical projects 322.27% upside. Exceptional opportunity in renal care innovation for aggressive traders.

$OUT Outfront Media maintains Outperform with 4.26% downside. Modest advertising and signage exposure.

$OXY Occidental Petroleum remains Outperform with 22.97% upside. Energy sector strength supports near-term gains.

$PGY Pagaya Technologies retains Buy with 48.65% upside. Fintech and AI-driven credit platforms make it a compelling growth play.

$PSNL Personalis continues Buy with 10.01% downside. Genomics and personalized medicine remain cautious but promising.

$PTON Peloton Interactive holds Outperform with 39.18% upside. Fitness tech and connected device trends drive growth.

$ROIV Roivant Sciences keeps Buy with 4.10% downside. Measured confidence in clinical-stage biotech development.

$ROKU Roku earns Strong Buy. Streaming technology and smart TV adoption attract tech traders.

$SEPN Sepertna maintains Buy with 22.12% upside. Consistent interest in biotech platform supports growth.

$SGRY Surgery Partners draws multiple positive ratings with 102.12% upside. Outpatient care expansion drives investor interest.

$SLB Schlumberger initiated Buy under $50 per share. Oilfield services recovery potential strong.

$SOC Sable Offshore maintains Buy with 452.27% upside. Massive speculative potential in offshore drilling.

$SU Suncor Energy remains Buy with 71.64% upside. Canadian energy fundamentals and commodity recovery boost prospects.

$T AT&T upgraded to Buy. Telecom stability with potential rebound after recent pullbacks.

$TBPH Theravance Biopharma retains Buy with 10.39% upside. Steady respiratory therapeutics innovation.

$TFC Truist Financial upgraded to Buy. Regional banking valuation-driven appeal.

$TGLS Tecnoglass continues Buy with nearly 100% upside. Architectural glass and construction demand drive growth.

$TLS Telos holds Outperform and Buy ratings with 3.09% upside. Low-risk, steady growth in cybersecurity.

$TSEM Tower Semiconductor keeps Outperform despite 28.15% downside. Semiconductor foundry caution remains.

$UI Ubiquiti remains Buy with 10.62% downside. Strong networking tech positioning, limited near-term upside.

$VOYA Voya Financial retains Outperform with 22.47% upside. Steady asset management and retirement growth.

$WULF Terawulf continues Buy with 29.23% upside. Crypto mining and energy-efficient infrastructure potential.

$WVE Wave Life Sciences maintains Outperform with 178.18% upside. Highly speculative biotech but potentially lucrative.

View All Headlines